BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16982211)

  • 21. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.
    Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y
    J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis.
    Yu M; Shao D; Liu J; Zhu J; Zhang Z; Xu J
    Int Immunopharmacol; 2007 Aug; 7(8):1076-82. PubMed ID: 17570324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation.
    Blander JM
    Methods Mol Biol; 2009; 512():99-117. PubMed ID: 19347275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage.
    Ma CX; Yin WN; Cai BW; Wu J; Wang JY; He M; Sun H; Ding JL; You C
    Chin Med J (Engl); 2009 Jul; 122(13):1575-81. PubMed ID: 19719951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate link between NF-kappaB activity and ubiquitin-like modifiers.
    Lang V; Rodríguez MS
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):853-7. PubMed ID: 18793150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin.
    Xu H; Liu P; Liang L; Danesh FR; Yang X; Ye Y; Zhan Z; Yu X; Peng H; Sun L
    Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
    Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
    Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delineating role of ubiquitination on nuclear factor-kappa B pathway by a computational modeling approach.
    Lee J; Choi K; Choi C
    Biochem Biophys Res Commun; 2010 Jan; 391(1):33-7. PubMed ID: 19895789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
    Fuchs O; Neuwirtová R
    Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A beginner's guide to NF-kappaB signaling pathways.
    Delhalle S; Blasius R; Dicato M; Diederich M
    Ann N Y Acad Sci; 2004 Dec; 1030():1-13. PubMed ID: 15659775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysine 63 polyubiquitination in immunotherapy and in cancer-promoting inflammation.
    Martinez-Forero I; Rouzaut A; Palazon A; Dubrot J; Melero I
    Clin Cancer Res; 2009 Nov; 15(22):6751-7. PubMed ID: 19887490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diverse ubiquitin signaling in NF-κB activation.
    Iwai K
    Trends Cell Biol; 2012 Jul; 22(7):355-64. PubMed ID: 22543051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circuitry of nuclear factor kappaB signaling.
    Hoffmann A; Baltimore D
    Immunol Rev; 2006 Apr; 210():171-86. PubMed ID: 16623771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination events.
    Verhelst K; Carpentier I; Beyaert R
    Cytokine Growth Factor Rev; 2011; 22(5-6):277-86. PubMed ID: 22119011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of NF-kappaB activation in intestinal immune homeostasis.
    Wullaert A
    Int J Med Microbiol; 2010 Jan; 300(1):49-56. PubMed ID: 19781989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway.
    Moynagh PN
    Trends Immunol; 2005 Sep; 26(9):469-76. PubMed ID: 16006187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of NF-κB subunits by ubiquitination.
    Collins PE; Colleran A; Carmody RJ
    Methods Mol Biol; 2015; 1280():355-70. PubMed ID: 25736760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Ectodysplasin and NFkappaB signalling pathways in odontogenesis.
    Courtney JM; Blackburn J; Sharpe PT
    Arch Oral Biol; 2005 Feb; 50(2):159-63. PubMed ID: 15721144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heritable defects of the human TLR signalling pathways.
    Puel A; Yang K; Ku CL; von Bernuth H; Bustamante J; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
    J Endotoxin Res; 2005; 11(4):220-4. PubMed ID: 16176658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.